A new study using a compound meant to mimic the medicinal effects of cannabinoids has found that activation of the body’s cannabinoid receptors – something which cannabis does naturally – can prevent, and treat hormone-sensitive prostate cancer. The study was published this month by the U.S. National Institute of Health. According to researchers of the study; “In the in vivo treatment, compound 4 [a synthetic cannabinoid] at 2 mg/kg, blocks the growth of LNCaP tumors and reduces the growth of PC-3 tumors generated in mice.” They continue, stating that cannabinoids are a “good potential anticancer agent against hormone-sensitive prostate cancer.”…
Author: WebTeam
A new study conducted by researchers at the Department of Pharmacology and Pharmacotherapy at Semmelweis University in Hungary, and published by the United States National Library of Medicine, has found promising evidence to suggest that cannabis may be a gastroprotectant. According to the study; “Stimulation of central angiotensin AT1 receptors via activation of cannabinoid CB1 receptors [something which cannabis does naturally] induces gastroprotection in a DAGL-dependent and vagus-mediated mechanism.” Here is the entire abstract from the study; The aim of the present study was to analyze whether angiotensin II via the endocannabinoid system can induce gastric mucosal protection, since transactivation…
A new study published in the journal Fundamental & Clinical Pharmacology has found that cannabidiol, a compound found in cannabis, may treat OCD (obsessive compulsive disorder). According to the start of the study’s abstract; “Cannabidiol (CBD), one of the main components of Cannabis sp, presents clinical and preclinical anxiolytic properties. Recent results using the marble-burying test (MBT) suggest that CBD can also induce anticompulsive-like effects.” “This study represents the first direct demonstration of the role of the endocannabinoid system on the antihyperalgesic effect of ankle joint mobilization.” Researchers at the University of Sao Paulo’s School of Medicine tested cannabidiol on…
A new study being published by the British Journal of Pharmacology, and published ahead of print this month by the National Institute of Health, has found that cannabidiol, a compound found naturally in cannabis, may be a safe and effective treatment for chemotherapy-induced neuropathic pain (CIPN). This discovery is a medical breakthrough, given that, according to the study’s researchers; “to date no one drug or drug class is considered to be effective for reversal of CIPN”. A new study being published by the British Journal of Pharmacology, and published ahead of print this month by the National Institute of Health,…
Recent research out of the University of Colorado, which was presented recently at the North American Spine Society’s annual meeting, has found that nearly 90% of those with back problems who consume cannabis find either great, or moderate relief from their cannabis consumption, and 81% believe it helps them as much, or more than traditional painkillers. For the study, researchers examined 184 patients at a Colorado spine center. According to Michael Finn, MD, a coauthor of the study, 19% reported using cannabis for pain relief. Of these people, slightly less than half – 46% – were qualified medical cannabis patients…
A study being published in next month’s issue of the Journal of Neurology, Neurosurgery & Psychiatry, and published online early by the National Institute of health, has found that THC (delta-9-tetrahydrocannabinol) can treat Parkinson’s disease. According to the study’s introduction; “Cannabinoids such as Δ9-tetrahydrocannabinol (Δ9-THC) are neuroprotective in animal and cell culture models of Parkinson’s disease (PD). In a PD cell culture model we recently demonstrated that Δ9-THC is neuroprotective through activation of the nuclear receptor peroxisomal proliferator-activated receptor γ (PPARγ)”. Researchers, while studying the effects of THC on these cell-culture models of Parkinson’s disease, found that; “Δ9-THC resulted in…
A new study published by the Journal of Neuroimmune Pharmacology has found that cannabis can treat multiple sclerosis by preventing inflammation in the brain and spinal cord. “Inflammation is part of the body’s natural immune response, but in cases like MS it gets out of hand,” says Drs. Ewa Kozela, co-author of the study. “Our study looks at how compounds isolated from marijuana can be used to regulate inflammation to protect the nervous system and its functions.” For the study researchers took isolated immune cells (which target and harm the brain and spinal cord) from paralyzed mice, and treated them…
In claims that are in vast contrast to those of the Drug Enforcement Administration and other government entities, the government-funded National Cancer Institute has a report published on its website which proclaims several benefits of cannabis and cannabinoids, citing numerous scientific studies to back their claims. The page was updated as recently as August. The report starts by explaining what cannabinoids are; “Cannabinoids are a group of 21-carbon–containing terpenophenolic compounds produced uniquely by Cannabis sativa and Cannabis indica species”, the report continues, “These plant-derived compounds may be referred to as phytocannabinoids. Although delta-9-tetrahydrocannabinol (THC) is the primary psychoactive ingredient, other…
There is no doubt that Jenny Kush was a bright and still-ascending star in the sky of cannabis activism. By the age of 34, Jenny had co-founded Moms For Marijuana International, was the host of her own weekly show SexPot on iCannabis Radio, campaigned tirelessly for wider access to medicinal marijuana and was one of her native Denver’s most outspoken and well-known cannabis activists. One of the campaign points of Moms For Marijuana – the fallacy that cannabis is as dangerous, if not more so, than alcohol – was underscored in the most tragic way by her death on August…
New research has shown that the non-hallucinogenic components of cannabis could act as effective anti-cancer agents. The anti-cancer properties of tetrahydrocannabinol (THC), the primary hallucinogenic component of cannabis, has been recognised for many years, but research into similar cannabis-derived compounds, known as cannabinoids, has been limited. The study was carried out by a team at St George’s, University of London. It has been published in the journal Anticancer Research. The team, led by Dr Wai Liu and colleagues carried out laboratory investigations using a number of cannabinoids, either alone or in combination with each other, to measure their anti-cancer actions…
